Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: and Evaluation

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2023 Mar 20

PMID 36936332

Authors

Hafiz Muhammad Bilal Khalid

Akhtar Rasul

Shahid Shah

Ghulam Abbas

Abid Mahmood

Affiliations

Soon will be listed here.

Abstract

Most biopharmaceutics classification system (BCS) class IV drugs have limited oral bioavailability due to poor solubility and poorer permeability. This work aims to investigate the possibility of utilizing disulfide bridged nanoparticles to improve BCS IV drug solubility and oral absorption. Disulfide bridged nanoparticles were made using thiolated sodium alginate (TSA) and thiolated eudragit RS100 (TERS100). This study used paclitaxel (PTL) as a model drug to create PTL-loaded nanoparticles using the air oxidation approach. PTL-loaded nanoparticles boosted the solubility of PTL by over 11 times (∼59 μg/mL). The nanoparticles had particle sizes of 103 nm, polydispersity indices of 0.034, and zeta potentials of -21 mV, respectively. Nanoparticles demonstrated 75.34% and 89.18% entrapment and loading efficiency of PTL, respectively. The PTL release data from nanoparticles had good sustained release properties. The effective permeability of PTL from nanoparticles was 2.19-fold higher than that of pure PTL suspension. The relative bioavailability of PTL with disulfide bridged nanoparticles was 237.11%, which was much higher than that of PTL suspension, according to the pharmacokinetic data. These results show that disulfide bridged nanoparticles have a wide range of clinical applications.

Citing Articles

Alginate coated mesoporous silica nanoparticles as oral delivery carrier of curcumin and quercetin to colon cancer: preparation, optimization, characterization, and anticancer activity.

Alallam B, Abdkadir E, Hayati A, Keong Y, Lim V Drug Deliv Transl Res. 2025; .

PMID: 39800814 DOI: 10.1007/s13346-024-01777-6.

S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications.

Tabish T, Hussain M, Zervou S, Myers W, Tu W, Xu J Redox Biol. 2024; 72:103144.

PMID: 38613920 PMC: 11026843. DOI: 10.1016/j.redox.2024.103144.

Conjugated Linoleic Acid-Carboxymethyl Chitosan Polymeric Micelles to Improve the Solubility and Oral Bioavailability of Paclitaxel.

Mubeen I, Abbas G, Shah S, Assiri A Pharmaceutics. 2024; 16(3).

PMID: 38543236 PMC: 10974779. DOI: 10.3390/pharmaceutics16030342.

Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy.

Xiang D, Zhou L, Yang R, Yuan F, Xu Y, Yang Y Int J Nanomedicine. 2024; 19:2091-2112.

PMID: 38476278 PMC: 10929151. DOI: 10.2147/IJN.S448715.

References

Abouelmagd S, Sun B, Chang A, Ku Y, Yeo Y . Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?. Mol Pharm. 2015; 12(3):997-1003. PMC: 4764376. DOI: 10.1021/mp500817h. View

Ho Y, Wu S, Mi F, Chiu Y, Yu S, Panda N . Thiol-modified chitosan sulfate nanoparticles for protection and release of basic fibroblast growth factor. Bioconjug Chem. 2009; 21(1):28-38. DOI: 10.1021/bc900208t. View

Zhao B, Du J, Zhang Y, Gu Z, Li Z, Cheng L . Polysaccharide-coated porous starch-based oral carrier for paclitaxel: Adsorption and sustained release in colon. Carbohydr Polym. 2022; 291:119571. DOI: 10.1016/j.carbpol.2022.119571. View

Khalid S, Abbas G, Hanif M, Shah S, Shah S, Jalil A . Thiolated sodium alginate conjugates for mucoadhesive and controlled release behavior of metformin microspheres. Int J Biol Macromol. 2020; 164:2691-2700. DOI: 10.1016/j.ijbiomac.2020.08.116. View

Zabaleta V, Ponchel G, Salman H, Agueros M, Vauthier C, Irache J . Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study. Eur J Pharm Biopharm. 2012; 81(3):514-23. DOI: 10.1016/j.ejpb.2012.04.001. View

Shetty A, Nagesh P, Setua S, Hafeez B, Jaggi M, Yallapu M . Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy. ACS Omega. 2020; 5(15):8982-8991. PMC: 7178800. DOI: 10.1021/acsomega.0c00793. View

Eltayb E, Aleanizy F, Alqahtani F, Alkahtani H, Ansari S, Alsarra I . Preparation and characterization of Meta-bromo-thiolactone calcium alginate nanoparticles. Saudi Pharm J. 2022; 30(7):946-953. PMC: 9315301. DOI: 10.1016/j.jsps.2022.05.008. View

Ma L, Kohli M, Smith A . Nanoparticles for combination drug therapy. ACS Nano. 2013; 7(11):9518-25. PMC: 3894659. DOI: 10.1021/nn405674m. View

Huang B, Tan Z, Bohinc K, Zhang S . Interaction between nanoparticles and charged phospholipid membranes. Phys Chem Chem Phys. 2018; 20(46):29249-29263. DOI: 10.1039/c8cp04740e. View

10.

Ayub A, Chiu H, Mat Yusuf S, Abd Kadir E, Ngalim S, Lim V . Biocompatible disulphide cross-linked sodium alginate derivative nanoparticles for oral colon-targeted drug delivery. Artif Cells Nanomed Biotechnol. 2019; 47(1):353-369. DOI: 10.1080/21691401.2018.1557672. View

11.

Dobrovolskaia M, Clogston J, Neun B, Hall J, Patri A, McNeil S . Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 2008; 8(8):2180-7. PMC: 2613576. DOI: 10.1021/nl0805615. View

12.

Qu X, Zou Y, He C, Zhou Y, Jin Y, Deng Y . Improved intestinal absorption of paclitaxel by mixed micelles self-assembled from vitamin E succinate-based amphiphilic polymers and their transcellular transport mechanism and intracellular trafficking routes. Drug Deliv. 2018; 25(1):210-225. PMC: 6058530. DOI: 10.1080/10717544.2017.1419513. View

13.

Gibson J, Khanal B, Zubarev E . Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc. 2007; 129(37):11653-61. DOI: 10.1021/ja075181k. View

14.

Sood A, Arora V, Shah J, Kotnala R, Jain T . Multifunctional gold coated iron oxide core-shell nanoparticles stabilized using thiolated sodium alginate for biomedical applications. Mater Sci Eng C Mater Biol Appl. 2017; 80:274-281. DOI: 10.1016/j.msec.2017.05.079. View

15.

Jana U, Mohanty A, Manna P, Mohanta G . Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100. Colloids Surf B Biointerfaces. 2013; 113:269-75. DOI: 10.1016/j.colsurfb.2013.09.001. View

16.

Bharate S, Kumar V, Singh G, Singh A, Gupta M, Singh D . Preclinical Development of -Based Botanical Lead IIIM-141 for Alzheimer's Disease: Chemical Standardization, Efficacy, Formulation Development, Pharmacokinetics, and Safety Pharmacology. ACS Omega. 2019; 3(8):9572-9585. PMC: 6644748. DOI: 10.1021/acsomega.8b00841. View

17.

Iqbal O, Shah S, Abbas G, Rasul A, Hanif M, Ashfaq M . Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery. Int J Biol Macromol. 2021; 182:2087-2096. DOI: 10.1016/j.ijbiomac.2021.05.199. View

18.

Ding Y, Sun T, Li S, Huang Q, Yue L, Zhu L . Oral Colon-Targeted Konjac Glucomannan Hydrogel Constructed through Noncovalent Cross-Linking by Cucurbit[8]uril for Ulcerative Colitis Therapy. ACS Appl Bio Mater. 2022; 3(1):10-19. DOI: 10.1021/acsabm.9b00676. View

19.

Kassem A, Farid R, Issa D, Khalil D, Abd-El-Razzak M, Saudi H . Development of mucoadhesive microbeads using thiolated sodium alginate for intrapocket delivery of resveratrol. Int J Pharm. 2015; 487(1-2):305-13. DOI: 10.1016/j.ijpharm.2015.04.010. View

20.

Li W, Li W, Wan Y, Wang L, Zhou T . Preparation, characterization and releasing property of antibacterial nano-capsules composed of ε-PL-EGCG and sodium alginate-chitosan. Int J Biol Macromol. 2022; 204:652-660. DOI: 10.1016/j.ijbiomac.2022.01.123. View